Market revenue in 2023 | USD 541.6 million |
Market revenue in 2030 | USD 1,593.8 million |
Growth rate | 16.7% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.45% in 2023. Horizon Databook has segmented the France structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
France is experiencing significant growth in its structural heart devices market, largely driven by the escalating incidence of CVDs countrywide. Recent statistics from the French Ministry of Health underscore the persistent threat posed by cardiovascular ailments, with heart disease and stroke remaining the primary causes of mortality.
Contributing factors include an aging populace and lifestyle choices such as sedentary living and unhealthy dietary patterns, amplifying the demand for advanced structural heart devices to effectively combat these conditions.
Highlighting the urgency of addressing these issues, the EU Structural Heart Disease Coalition convened at the French National Assembly in October 2023, following an invitation from Deputy Paul Christophe. Discussions focused on the early detection of SHD and its crucial role in promoting healthy aging, reflecting the increasing prominence of aging-related concerns within the French population.
Horizon Databook provides a detailed overview of country-level data and insights on the France structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into France structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account